CASI Pharma (CASI) Reports Q2 Loss of $0.52

CASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.52). Revenue for the quarter came in at $3.98 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• Biohaven names new discovery head as CSO shifts to part-time role
• CCC Intelligent Solutions explores potential sale with Morgan Stanley - Reuters